Psychiatry and Neurology, Neurology · Swedesboro, NJ
NPI
1992738470
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
100 Lexington Rd
Swedesboro, NJ, 08085
Phone (856) 467-7360
Groups this clinician bills Medicare through
Medicare paid, 2024
$99K
1,254 services
Medicare patients, 2024
393
Average age 71
Drug cost, 2024
$2.9M
5,350 prescriptions
Company payments, 2025
$542
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Susan D Lotkowski was code 99215 (office e&m - established), 420 times for 247 patients. In total Susan D Lotkowski billed 1,254 services in 21 codes, and Medicare paid $99K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-03.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 420 | 247 | $139.15 | $58K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 339 | 213 | $13.12 | $4,449 |
| 99214 Office E&M - Established | Office | 162 | 136 | $93.24 | $15K |
| 96127 Behavioral Health Services | Office | 120 | 95 | $3.55 | $426 |
| 95816 Neurologic | Facility | 48 | 48 | $46.29 | $2,222 |
| 99205 Office E&M - New | Office | 36 | 36 | $174.04 | $6,265 |
| 95886 Electrical Nerve Conductivity | Office | 36 | 23 | $81.40 | $2,931 |
| 95910 Electrical Nerve Conductivity | Office | 21 | 19 | $147.76 | $3,103 |
| 99204 Office E&M - New | Office | 13 | 13 | $139.97 | $1,820 |
By year: 2022 $96K for 911 services; 2023 $88K for 774 services; 2024 $99K for 1,254 services.
Medicare prescription drug claims, 2024
In 2024, the drug Susan D Lotkowski prescribed most often to Medicare patients was Memantine Hcl, with 402 prescriptions and refills. In total Susan D Lotkowski wrote 5,350 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Memantine Hcl Generic | 402 | 662 | 91 | $9,596 |
| Donepezil Hcl Generic | 316 | 663 | 81 | $5,077 |
| Aimovig Autoinjector Erenumab-Aooe | 208 | 258 | 30 | $194K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 205 | 393 | 47 | $5,681 |
| Levetiracetam Generic | 199 | 299 | 33 | $7,936 |
| Memantine Hcl Er Memantine Hcl | 197 | 389 | 43 | $14K |
| Duloxetine Hcl Generic | 187 | 387 | 43 | $3,952 |
| Topiramate Generic | 151 | 272 | 36 | $2,347 |
| Ubrelvy Ubrogepant | 132 | 139 | 36 | $197K |
| Lamotrigine Generic | 123 | 234 | 24 | $2,058 |
| Gabapentin Generic | 123 | 193 | 31 | $2,145 |
| Sertraline Hcl Generic | 112 | 188 | 25 | $656 |
| Trazodone Hcl Generic | 110 | 158 | 16 | $617 |
| Pregabalin Generic | 108 | 128 | 23 | $3,131 |
| Mirtazapine Generic | 103 | 186 | 26 | $2,594 |
Brand drugs: 991 claims; generic drugs: 4,327 claims; opioid claims: 41.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Susan D Lotkowski $542 ($542 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $65.94.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 4 | $65.94 |
| Biogen, Inc. BIIB | 2 | $51.94 |
| CSL Behring CSL.AX | 1 | $47.74 |
| UCB, Inc. UCB.BR | 2 | $40.01 |
| Boston Scientific Corporation BSX | 1 | $39.64 |
| Eisai Inc. 4523.T | 2 | $37.46 |
| Teva Pharmaceuticals USA, Inc. TEVA | 2 | $35.8 |
| Amneal Pharmaceuticals LLC AMRX | 2 | $33.42 |
| Janssen Biotech, Inc. JNJ | 1 | $28.93 |
| Lilly USA, LLC LLY | 1 | $22.56 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.